- Recent Funding
- Investors
- HAT Sicaf
HAT Sicaf portfolio
HAT Sicaf has 1 portfolio company on record at Recent Funding. Its most recent investment on record is Huma Therapeutics's $80M Series B+ round in July 2024, alongside Leaps by Bayer, Hitachi Ventures and AstraZeneca. That company is in AI agents.
What HAT Sicaf invests in
- AI agents · 1 · 100%
- Health and bio · 1 · 100%
- Data and analytics · 1 · 100%
How HAT Sicaf invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $80M |
Share is of the 1 round on Recent Funding that name HAT Sicaf. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
HAT Sicaf portfolio companies
HHuma Therapeutics$80MSeries B+ · Jul 2024
| Company | Round with HAT Sicaf | Total raised | Latest raise |
|---|---|---|---|
AI agents |
Series B+ · $80M | $118M | Sep 11, 2024 round |
Most frequent co-investors
HHitachi Ventures1 shared round · last Jul 16, 2024
AAstraZeneca1 shared round · last Jul 16, 2024
LLeaps by Bayer1 shared round · last Jul 16, 2024
Similar investors
CCarrick Capital Partners1 company · 1 deal in 12 moCCopper Sky Capital1 company · 1 deal in 12 mo
FFT Partners1 company · 1 deal in 12 mo
IImprobable1 company · 1 deal in 12 mo
IIona Star1 company · 1 deal in 12 mo
MMento VC1 company · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (AI agents).
Portfolio companies are the companies on Recent Funding with a round that lists HAT Sicaf, which is a subset of its real portfolio. API: /api/v1/investors/hat-sicaf (get a free API key). More: the most active VC firms and new venture capital funds.